SALT LAKE CITY--(BUSINESS WIRE)--Oct. 17, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced that a Nasdaq Listing Qualifications Panel has determined the Company is compliant with the continued listing standards of the Nasdaq Stock Market, including the Nasdaq Marketplace Rule 4310(c)(14) related to the filing of periodic reports with the U.S. Securities and Exchange Commission. Accordingly, the Panel has determined that the Company's common stock will continue to be listed on The Nasdaq Stock Market.
USANA filed its amended Form 10-Q on October 10, 2007, which included financial statements as of June 30, 2007 in compliance with SEC regulations related to interim financial statements, and certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing.
Gilbert A. Fuller, USANA's Executive Vice President and Chief Financial Officer, said, "The Nasdaq Panel considered the entire record before it, including materials related to adverse publicity directed against USANA, and the resignation of our former accounting firm. The Panel specifically recognized that USANA's Audit Committee completed an investigation of the allegations made by third-party detractors, and that the Audit Committee found no merit to them. The Panel also noted that USANA's new auditor, PricewaterhouseCoopers LLP, undertook a thorough acceptance process before taking on USANA as a new client and completed its review process for the June 30, 2007 Form 10-Q."
The Panel's determination letter dated October 16, 2007, concluded: "Nothing revealed at the hearing raised additional doubts for the Panel about the integrity of management, the Company's business or its regulatory compliance process."
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: Investors Contact:USANA Health Sciences Inc.Riley Timmer, Investor Relations, 801-954-7100investor.relations@us.usana.comorMedia Contact:EdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
Wednesday, October 17, 2007
Tuesday, October 16, 2007
USANA Health Sciences Announces Third Quarter 2007 Financial Results
-- Earnings Per Share Increased 25.0%, Year-over-Year, to $0.70 --
-- Net Sales Increased 15.5%, Year-over-Year, to $106.2 Million --
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 16, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for the fiscal third quarter ending September 29, 2007.
Financial Performance
Net sales in the third quarter of 2007 increased by 15.5% to $106.2 million, compared with $92.0 million in the third quarter of the prior year. Net sales growth for the third quarter of 2007 resulted primarily from a 24.1% net increase in the number of active Associates, meaning those who have purchased products directly from the Company in the preceding three months, either for personal consumption or for resale. Foreign currency fluctuations accounted for 3.4 percentage points of the year-over-year increase in net sales for the third quarter of 2007.
Earnings from continuing operations in the third quarter of 2007 grew by 7.5% to $17.3 million, or 16.3% of net sales, compared with $16.1 million, or 17.5% of net sales, in the third quarter of the prior year. Earnings per share from continuing operations increased by 25.0% in the third quarter of 2007 to $0.70 per share, compared with $0.56 per share in the third quarter of the prior year. This increase was in part due to aggressive stock repurchases and a lower than expected effective tax rate of 31.4%, offsetting higher Selling General and Administrative expenses.
For the nine-month period ended September 29, 2007, consolidated net sales were $314.4 million, an increase of 17.7%, compared with $267.0 million in the first nine months of 2006. Earnings per share from continuing operations increased 22.7% in the first nine months of 2007 to $2.00, compared with $1.63 in the first nine months of 2006.
During the third quarter of 2007, the Company repurchased 180 thousand shares for an investment of $6.6 million. During the first nine months of 2007, the Company repurchased approximately 1.9 million shares for an investment of about $80 million. As of the end of the third quarter, there was about $50 million remaining under the current stock buyback authorization.
Regional Results
During the third quarter of 2007, net sales in North America, the Company's most mature region, increased by 10.1% to $66.6 million, compared with the third quarter of the prior year. This growth was driven primarily by a 16.7% net improvement in the number of active Associates in this region to 105,000. Along with double-digit growth in Canada, sales in Mexico increased by 19.3% over the third quarter of last year.
"We are pleased to have achieved double-digit growth in the number of active Associates and in net sales in the North American region," said Dave Wentz, the Company's President. "Both the Canadian and Mexican markets have contributed to this region's strong sales growth."
During the third quarter of 2007, net sales in the Asia Pacific region increased by 25.7% to $39.6 million, compared with the third quarter of the prior year. The growth in this region was led by double-digit, year-over-year growth in Hong Kong and the Australia-New Zealand markets. Malaysia continues to show steady growth as a new market, contributing $4.9 million of incremental revenue in the third quarter, an 8.6% increase, compared with the second quarter. The number of active Associates in the Asia Pacific region increased by 36.4% to 75,000, compared with 55,000 in the third quarter of the prior year. The number of Associates in our newest market, Malaysia, grew to 12,000 in just its third quarter of operations.
"The Asia Pacific region continues to be a healthy market for USANA," continued Wentz. "This region has been contributing an increasing share of our growth, led by Hong Kong and Australia-New Zealand, and we anticipate that the Malaysian market will play an increasingly important role in this region. We continue to focus the majority of our efforts on solidifying and growing our 13 core markets."
Outlook
Today, the Company is providing financial guidance for the fourth quarter of 2007 and its initial look at the full year 2008. Based on its current business trends, the Company believes that net sales for the fourth quarter of 2007 will be between $108 million and $110 million, a growth rate of 10% to 12%, compared with the prior year fourth quarter.
Earnings per share are expected to be between $0.66 and $0.68 for the fourth quarter of 2007. Accordingly, for the year 2007, sales are now expected to be between $422 million and $424 million, excluding revenues from our discontinued third-party contract manufacturing business, with earnings per share between $2.66 and $2.68.
Additionally, in the Company's first look at full-year 2008, we believe that both net sales and earnings per share will grow 10% to 13%, compared with the full-year 2007. These earnings per share estimates assume an effective tax rate of approximately 36.0% for the fourth quarter of 2007 and for the full-year 2008.
Gilbert A. Fuller, the Company's executive vice president and chief financial officer, said, "Our strategy of supporting our Associates both domestically and internationally, continues to pay off and produce strong financial results. Going forward, we likely will continue to buy back shares as a way of returning value to our shareholders. We are proud to offer the finest nutritional and personal care products in the industry."
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 17, 2007 at 11:00 AM ET. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. USANA Health Sciences, Inc.
Consolidated Statements of Earnings
(In thousands, except per share data)
Quarter Ended
-----------------------
30-Sep-06 29-Sep-07
---------- -----------
(Unaudited) (Unaudited)
Net sales $ 91,967 $106,181
Cost of sales 20,274 21,960
---------- -----------
Gross profit 71,693 84,221
Operating expenses
Associate incentives 36,994 43,021
Selling, general and administrative 17,798 23,053
Research and development 830 864
---------- -----------
Earnings from operations 16,071 17,283
Other income 65 (270)
---------- -----------
Earnings before income taxes 16,136 17,013
Income taxes 5,698 5,350
---------- -----------
Income from continuing operations 10,438 11,663
Income (Loss) from discontinued operations (215) (405)
NET EARNINGS $ 10,223 $ 11,258
========== ===========
Earnings per share - diluted
Continuing operations $ 0.56 $ 0.70
Discontinued operations $ (0.01) $ (0.02)
---------- -----------
Net Earnings $ 0.55 $ 0.68
========== ===========
Weighted average shares outstanding - diluted 18,486 16,613
========== ===========
USANA Health Sciences, Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
30-Dec-06 29-Sep-07
------------ -------------
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents $ 27,029 $ 11,718
Inventories 22,483 21,058
Other current assets 11,103 12,841
------------ -------------
Total current assets 60,615 45,617
Property and equipment, net 30,323 45,838
Goodwill 5,690 5,690
Other assets 3,374 4,503
------------ -------------
Total assets $ 100,002 $ 101,648
============ =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 10,241 $ 7,910
Other current liabilities 29,564 32,507
------------ -------------
Total current liabilities 39,805 40,417
------------ -------------
Long-term liabilities
Line of Credit - 34,625
Other long-term liabilities - 1,673
Stockholders' equity 60,197 24,933
------------ -------------
Total liabilities and stockholders' equity $ 100,002 $ 101,648
============ =============
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
30-Sep-06 29-Sep-07
--------------- ----------------
(Unaudited) (Unaudited)
Region
-----------------------------------
North America
United States $39,425 42.9% $ 42,455 40.0%
Canada 16,574 18.0% 18,792 17.7%
Mexico 4,503 4.9% 5,372 5.1%
------- ------ -------- ------
North America Total 60,502 65.8% $ 66,619 62.8%
Asia Pacific
Australia-New Zealand 12,297 13.4% 14,163 13.3%
Hong Kong 4,582 5.0% 6,876 6.5%
Japan 2,357 2.5% 2,395 2.3%
Taiwan 5,509 6.0% 5,354 5.0%
South Korea 2,117 2.3% 1,634 1.5%
Singapore 4,603 5.0% 4,209 4.0%
Malaysia - 0.0% 4,931 4.6%
------- ------ -------- ------
Asia Pacific Total 31,465 34.2% 39,562 37.2%
------- ------ -------- ------
Consolidated $91,967 100.0% $106,181 100.0%
======= ====== ======== ======
Active Associates by Region
As of
--------------------------------
30-Sep-06 29-Sep-07
--------------- ---------------
(Unaudited) (Unaudited)
Region
------------------------------------
North America
United States 58,000 40.0% 63,000 35.0%
Canada 22,000 15.2% 28,000 15.5%
Mexico 10,000 6.9% 14,000 7.8%
------- ------ ------- ------
North America Total 90,000 62.1% 105,000 58.3%
Asia Pacific
Australia-New Zealand 18,000 12.4% 21,000 11.7%
Hong Kong 8,000 5.5% 13,000 7.2%
Japan 4,000 2.7% 5,000 2.8%
Taiwan 13,000 9.0% 14,000 7.8%
South Korea 2,000 1.4% 2,000 1.1%
Singapore 10,000 6.9% 8,000 4.4%
Malaysia - 0.0% 12,000 6.7%
------- ------ ------- ------
Asia Pacific Total 55,000 37.9% 75,000 41.7%
------- ------ ------- ------
Total 145,000 100.0% 180,000 100.0%
======= ====== ======= ======
Active Preferred Customers by Region
As of
------------------------------
30-Sep-06 29-Sep-07
-------------- --------------
(Unaudited) (Unaudited)
Region
--------------------------------------
North America
United States 49,000 64.5% 51,000 64.6%
Canada 18,000 23.7% 17,000 21.5%
Mexico 2,000 2.6% 3,000 3.8%
------ ------ ------ ------
North America Total 69,000 90.8% 71,000 89.9%
Asia Pacific
Australia-New Zealand 6,000 7.9% 6,000 7.5%
Hong Kong ** 0.0% 1,000 1.3%
Japan 1,000 1.3% 1,000 1.3%
Taiwan ** 0.0% ** 0.0%
South Korea ** 0.0% ** 0.0%
Singapore ** 0.0% ** 0.0%
Malaysia - 0.0% ** 0.0%
------ ------ ------ ------
Asia Pacific Total 7,000 9.2% 8,000 10.1%
------ ------ ------ ------
Total 76,000 100.0% 79,000 100.0%
====== ====== ====== ======
** Count of Active Preferred Customers is less than 500.
CONTACT:USANSA Health SciencesInvestor Relations:Riley Timmer, 801-954-7922investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
-- Net Sales Increased 15.5%, Year-over-Year, to $106.2 Million --
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 16, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for the fiscal third quarter ending September 29, 2007.
Financial Performance
Net sales in the third quarter of 2007 increased by 15.5% to $106.2 million, compared with $92.0 million in the third quarter of the prior year. Net sales growth for the third quarter of 2007 resulted primarily from a 24.1% net increase in the number of active Associates, meaning those who have purchased products directly from the Company in the preceding three months, either for personal consumption or for resale. Foreign currency fluctuations accounted for 3.4 percentage points of the year-over-year increase in net sales for the third quarter of 2007.
Earnings from continuing operations in the third quarter of 2007 grew by 7.5% to $17.3 million, or 16.3% of net sales, compared with $16.1 million, or 17.5% of net sales, in the third quarter of the prior year. Earnings per share from continuing operations increased by 25.0% in the third quarter of 2007 to $0.70 per share, compared with $0.56 per share in the third quarter of the prior year. This increase was in part due to aggressive stock repurchases and a lower than expected effective tax rate of 31.4%, offsetting higher Selling General and Administrative expenses.
For the nine-month period ended September 29, 2007, consolidated net sales were $314.4 million, an increase of 17.7%, compared with $267.0 million in the first nine months of 2006. Earnings per share from continuing operations increased 22.7% in the first nine months of 2007 to $2.00, compared with $1.63 in the first nine months of 2006.
During the third quarter of 2007, the Company repurchased 180 thousand shares for an investment of $6.6 million. During the first nine months of 2007, the Company repurchased approximately 1.9 million shares for an investment of about $80 million. As of the end of the third quarter, there was about $50 million remaining under the current stock buyback authorization.
Regional Results
During the third quarter of 2007, net sales in North America, the Company's most mature region, increased by 10.1% to $66.6 million, compared with the third quarter of the prior year. This growth was driven primarily by a 16.7% net improvement in the number of active Associates in this region to 105,000. Along with double-digit growth in Canada, sales in Mexico increased by 19.3% over the third quarter of last year.
"We are pleased to have achieved double-digit growth in the number of active Associates and in net sales in the North American region," said Dave Wentz, the Company's President. "Both the Canadian and Mexican markets have contributed to this region's strong sales growth."
During the third quarter of 2007, net sales in the Asia Pacific region increased by 25.7% to $39.6 million, compared with the third quarter of the prior year. The growth in this region was led by double-digit, year-over-year growth in Hong Kong and the Australia-New Zealand markets. Malaysia continues to show steady growth as a new market, contributing $4.9 million of incremental revenue in the third quarter, an 8.6% increase, compared with the second quarter. The number of active Associates in the Asia Pacific region increased by 36.4% to 75,000, compared with 55,000 in the third quarter of the prior year. The number of Associates in our newest market, Malaysia, grew to 12,000 in just its third quarter of operations.
"The Asia Pacific region continues to be a healthy market for USANA," continued Wentz. "This region has been contributing an increasing share of our growth, led by Hong Kong and Australia-New Zealand, and we anticipate that the Malaysian market will play an increasingly important role in this region. We continue to focus the majority of our efforts on solidifying and growing our 13 core markets."
Outlook
Today, the Company is providing financial guidance for the fourth quarter of 2007 and its initial look at the full year 2008. Based on its current business trends, the Company believes that net sales for the fourth quarter of 2007 will be between $108 million and $110 million, a growth rate of 10% to 12%, compared with the prior year fourth quarter.
Earnings per share are expected to be between $0.66 and $0.68 for the fourth quarter of 2007. Accordingly, for the year 2007, sales are now expected to be between $422 million and $424 million, excluding revenues from our discontinued third-party contract manufacturing business, with earnings per share between $2.66 and $2.68.
Additionally, in the Company's first look at full-year 2008, we believe that both net sales and earnings per share will grow 10% to 13%, compared with the full-year 2007. These earnings per share estimates assume an effective tax rate of approximately 36.0% for the fourth quarter of 2007 and for the full-year 2008.
Gilbert A. Fuller, the Company's executive vice president and chief financial officer, said, "Our strategy of supporting our Associates both domestically and internationally, continues to pay off and produce strong financial results. Going forward, we likely will continue to buy back shares as a way of returning value to our shareholders. We are proud to offer the finest nutritional and personal care products in the industry."
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 17, 2007 at 11:00 AM ET. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. USANA Health Sciences, Inc.
Consolidated Statements of Earnings
(In thousands, except per share data)
Quarter Ended
-----------------------
30-Sep-06 29-Sep-07
---------- -----------
(Unaudited) (Unaudited)
Net sales $ 91,967 $106,181
Cost of sales 20,274 21,960
---------- -----------
Gross profit 71,693 84,221
Operating expenses
Associate incentives 36,994 43,021
Selling, general and administrative 17,798 23,053
Research and development 830 864
---------- -----------
Earnings from operations 16,071 17,283
Other income 65 (270)
---------- -----------
Earnings before income taxes 16,136 17,013
Income taxes 5,698 5,350
---------- -----------
Income from continuing operations 10,438 11,663
Income (Loss) from discontinued operations (215) (405)
NET EARNINGS $ 10,223 $ 11,258
========== ===========
Earnings per share - diluted
Continuing operations $ 0.56 $ 0.70
Discontinued operations $ (0.01) $ (0.02)
---------- -----------
Net Earnings $ 0.55 $ 0.68
========== ===========
Weighted average shares outstanding - diluted 18,486 16,613
========== ===========
USANA Health Sciences, Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
30-Dec-06 29-Sep-07
------------ -------------
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents $ 27,029 $ 11,718
Inventories 22,483 21,058
Other current assets 11,103 12,841
------------ -------------
Total current assets 60,615 45,617
Property and equipment, net 30,323 45,838
Goodwill 5,690 5,690
Other assets 3,374 4,503
------------ -------------
Total assets $ 100,002 $ 101,648
============ =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 10,241 $ 7,910
Other current liabilities 29,564 32,507
------------ -------------
Total current liabilities 39,805 40,417
------------ -------------
Long-term liabilities
Line of Credit - 34,625
Other long-term liabilities - 1,673
Stockholders' equity 60,197 24,933
------------ -------------
Total liabilities and stockholders' equity $ 100,002 $ 101,648
============ =============
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
30-Sep-06 29-Sep-07
--------------- ----------------
(Unaudited) (Unaudited)
Region
-----------------------------------
North America
United States $39,425 42.9% $ 42,455 40.0%
Canada 16,574 18.0% 18,792 17.7%
Mexico 4,503 4.9% 5,372 5.1%
------- ------ -------- ------
North America Total 60,502 65.8% $ 66,619 62.8%
Asia Pacific
Australia-New Zealand 12,297 13.4% 14,163 13.3%
Hong Kong 4,582 5.0% 6,876 6.5%
Japan 2,357 2.5% 2,395 2.3%
Taiwan 5,509 6.0% 5,354 5.0%
South Korea 2,117 2.3% 1,634 1.5%
Singapore 4,603 5.0% 4,209 4.0%
Malaysia - 0.0% 4,931 4.6%
------- ------ -------- ------
Asia Pacific Total 31,465 34.2% 39,562 37.2%
------- ------ -------- ------
Consolidated $91,967 100.0% $106,181 100.0%
======= ====== ======== ======
Active Associates by Region
As of
--------------------------------
30-Sep-06 29-Sep-07
--------------- ---------------
(Unaudited) (Unaudited)
Region
------------------------------------
North America
United States 58,000 40.0% 63,000 35.0%
Canada 22,000 15.2% 28,000 15.5%
Mexico 10,000 6.9% 14,000 7.8%
------- ------ ------- ------
North America Total 90,000 62.1% 105,000 58.3%
Asia Pacific
Australia-New Zealand 18,000 12.4% 21,000 11.7%
Hong Kong 8,000 5.5% 13,000 7.2%
Japan 4,000 2.7% 5,000 2.8%
Taiwan 13,000 9.0% 14,000 7.8%
South Korea 2,000 1.4% 2,000 1.1%
Singapore 10,000 6.9% 8,000 4.4%
Malaysia - 0.0% 12,000 6.7%
------- ------ ------- ------
Asia Pacific Total 55,000 37.9% 75,000 41.7%
------- ------ ------- ------
Total 145,000 100.0% 180,000 100.0%
======= ====== ======= ======
Active Preferred Customers by Region
As of
------------------------------
30-Sep-06 29-Sep-07
-------------- --------------
(Unaudited) (Unaudited)
Region
--------------------------------------
North America
United States 49,000 64.5% 51,000 64.6%
Canada 18,000 23.7% 17,000 21.5%
Mexico 2,000 2.6% 3,000 3.8%
------ ------ ------ ------
North America Total 69,000 90.8% 71,000 89.9%
Asia Pacific
Australia-New Zealand 6,000 7.9% 6,000 7.5%
Hong Kong ** 0.0% 1,000 1.3%
Japan 1,000 1.3% 1,000 1.3%
Taiwan ** 0.0% ** 0.0%
South Korea ** 0.0% ** 0.0%
Singapore ** 0.0% ** 0.0%
Malaysia - 0.0% ** 0.0%
------ ------ ------ ------
Asia Pacific Total 7,000 9.2% 8,000 10.1%
------ ------ ------ ------
Total 76,000 100.0% 79,000 100.0%
====== ====== ====== ======
** Count of Active Preferred Customers is less than 500.
CONTACT:USANSA Health SciencesInvestor Relations:Riley Timmer, 801-954-7922investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
Wednesday, October 10, 2007
USANA Health Sciences Inc. Files Amended Form 10-Q for Second Quarter of 2007
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 10, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced today that it has filed an amended Form 10-Q with the Securities and Exchange Commission (SEC) and NASDAQ.
The amended report includes financial statements as of June 30, 2007 that comply with the reporting requirements of Regulation S-X and subject to the requirements of Statement of Auditing Standards No. 100. Additionally, the amended report includes the certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing. An electronic copy of this amended Form 10-Q can be found at http://www.usanahealthsciences.com.
With the filing of the amended quarterly report, the Company now believes that it is in full compliance with all Form 10-Q filing requirements for continued NASDAQ listing set forth in Marketplace Rule 4310(C)(14).
The Company's Audit Committee appointed PricewaterhouseCoopers, LLP as its new independent registered public accounting firm in early September.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100 (Investor Relations)investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
The amended report includes financial statements as of June 30, 2007 that comply with the reporting requirements of Regulation S-X and subject to the requirements of Statement of Auditing Standards No. 100. Additionally, the amended report includes the certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing. An electronic copy of this amended Form 10-Q can be found at http://www.usanahealthsciences.com.
With the filing of the amended quarterly report, the Company now believes that it is in full compliance with all Form 10-Q filing requirements for continued NASDAQ listing set forth in Marketplace Rule 4310(C)(14).
The Company's Audit Committee appointed PricewaterhouseCoopers, LLP as its new independent registered public accounting firm in early September.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100 (Investor Relations)investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
Tuesday, October 9, 2007
USANA Schedules Third Quarter 2007 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 9, 2007--USANA Health Sciences, Inc. (NASDAQ:USNA) today announced that third quarter results will be released after the close of market Tuesday, October 16, 2007. USANA executives will hold a conference call to discuss the announcement with analysts and institutional investors on Wednesday, October 17, 2007 at 11:00 a.m. EDT.
The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.
The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.
The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
Subscribe to:
Comments (Atom)
